The American Society of Gene Therapy and NPG Announce a New Publishing Partnership
The American Society of Gene Therapy (ASGT) and Nature Publishing Group (NPG) are pleased to announce a new publishing partnership. From January 2007, NPG will publish the Society’s leading international title, Molecular Therapy (MT), and the journal will re-launch with a new look in print and online.
(PRWEB) April 20, 2006 -- The American Society of Gene Therapy (ASGT) and Nature Publishing Group (NPG) are pleased to announce a new publishing partnership. From January 2007, NPG will publish the Society’s leading international title, Molecular Therapy (MT), and the journal will re-launch with a new look in print and online.
The journal’s focus will not change and MT will continue to publish high-quality research and review articles. David A. Williams, MD, will continue to serve as Editor-in-Chief and Robert M. Frederickson, PhD will remain as Managing Editor. “In less than a decade, Molecular Therapy has become a leading journal for reporting advancements in molecular and cellular therapy, including gene therapy. We believe the move to NPG will enhance the appearance and impact of the journal and allow continued growth in the field,” said Dr. Williams.
Molecular Therapy presents important, peer-reviewed studies on key issues in gene transfer, gene and cell therapies, experimental models for correction of genetic and acquired disease and clinical trials. MT has become recognized as one of the most prestigious journals in the field. MT is ranked in three ISI categories and has an impact factor of 5.204*.
ASGT named NPG as its new publisher to help best meet its goals for developing Molecular Therapy. “NPG is delighted to enter into this important partnership with the ASGT. The partnership fulfils our mission to provide the highest quality information to the global scientific community. We look forward to expanding the journal’s readership and strengthening its position as the essential reference for all professionals related to gene therapy,” said Annette Thomas, NPG’s Managing Director, about the new partnership.
| | - Thomson-ISI, PA, USA 2005
|
About ASGT: The ASGT is a professional medical and scientific organization dedicated to the understanding, development and application of gene and related cell and nucleic acid therapies. Established in 1996, the society has nearly 2,000 members worldwide. Mark A. Kay, MD, PhD, is president of the ASGT.
About NPG: Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, is the world's most highly-cited weekly multidisciplinary journal and was first published in 1869. Other publications and services include Nature research journals, Nature Reviews, Nature Clinical Practice, a range of prestigious academic journals, including society-owned publications, news content and scientific career information from Naturejobs.
NPG is a global company, with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Gurgaon, Mexico City and Basingstoke. For more information, please go to http://www.nature.com.
Contact details:
Joyce-Rachel John
Nature Publishing Group
+1 212 726 9214
75 Varick Street, 9th Floor
New York, NY 10013-1917
USA
Links:
http://www.nature.com
http://www.ASGT.org
http://www.editorialmanager.com/mthe
This press release is also available at http://www.nature.com/press_releases/NPG_to_publish_MT.pdf.
For all NPG press releases, go to http://www.nature.com/press_releases.html.
###
|
